Completed NA INTERVENTIONAL 2-arm NCT00820625

Long-Standing Persistant Atrial Fibrillation-Pulmonary Vein Isolation With or Without Ablation (Alster-Lost)

Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation - Pulmonary Vein Isolation With or Without Ablation of Complex Fragmented Atrial Potentials

Sponsor: Asklepios proresearch

Conditions Atrial Fibrillation Tachycardia

Interventions pulmonary vein isolation pulmonary vein isolation with additional ablation of fragmented potentials

Updated 6 times since 2017 Last updated: Feb 6, 2017 Started: May 31, 2008 Primary completion: Feb 28, 2017 Completion: Feb 28, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00820625, this NA trial focuses on Atrial Fibrillation and Tachycardia and remains completed. Sponsored by Asklepios proresearch, it has been updated 6 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE4 → NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Asklepios proresearch

Data source: Asklepios proresearch

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamburg, Germany